Evidence map›Paper›PMID 32316791›Full record

ArticleThe Journal of international medical research2020

Exploring potential biomarkers for lung adenocarcinoma using LC-MS/MS metabolomics.

Liang Mo, Bing Wei, Renji Liang, Zhi Yang, Shouzhi Xie, Shengrong Wu, Yong You

Abstract read
In one paragraph

Article in The Journal of international medical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Study on the Metabonomics Mechanism of Mongolian Medical Andai Therapy on Healthy People.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Liang MoDepartment of Thoracic Surgery, the First Affiliated Hospital of University of South China, Hengyang, Hunan Province, China.
Bing WeiDepartment of Thoracic Surgery, the First Affiliated Hospital of University of South China, Hengyang, Hunan Province, China.
Renji LiangDepartment of Thoracic Surgery, the First Affiliated Hospital of University of South China, Hengyang, Hunan Province, China.
Zhi YangDepartment of Thoracic Surgery, the First Affiliated Hospital of University of South China, Hengyang, Hunan Province, China.
Shouzhi XieDepartment of Thoracic Surgery, the First Affiliated Hospital of University of South China, Hengyang, Hunan Province, China.
Shengrong WuDepartment of Thoracic Surgery, the First Affiliated Hospital of University of South China, Hengyang, Hunan Province, China.
Yong YouMedical College, University of South China, Hengyang, Hunan Province, China.ORCID https://orcid.org/0000-0002-5844-5905

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adenocarcinoma of LungAgedBiomarkers, TumorChromatography, LiquidFemaleHumansMaleMetabolomicsMiddle AgedPrognosisTandem Mass SpectrometryBiomarkers, TumorbiomarkerdiagnosisLC-MS/MSLung cancermetabolitemetabolomics

Identifiers

PMID32316791
PMCPMC7177994

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.